SBI Contra Fund is an open-ended equity fund under the value-oriented category. It was launched on July 14, 1999. The investment objective of the SBI Contra Fund is to generate long term wealth by investing in a well-diversified portfolio of equity securities as well as following a contrarian investment strategy. However, the return from this is not guaranteed.
SBI Contra Fund follows a mix of the bottom-up and top-down approach to stock picking. You can invest a minimum sum of Rs. 500 in SBI Contra Fund sip plan. There are 2 different investment options available which are SBI Contra Fund dividend and SBI Contra Fund growth scheme. But for long term capital appreciation, you must invest in SBI Contra Fund growth plan.
- SBI Contra Fund portfolio allocation includes 93.05% in equity stocks out of which 41% in large-cap, 34.46% in small-cap and 16.57% in mid-cap stocks.
- Professional fund managers take the decision of sectoral allocation while investing in SBI Contra Fund regular plan dividend plan and SBI Contra Fund regular growth plan.
- Investments in this mutual fund scheme online in India is very easy and time-saving.
- Since this fund was launched in 1999, so it has survived ups and downs of different market cycles and as a result, has gained a huge trust of the investors.
S.No. | Holding Name | Net Assets (in %) |
1 | Financial Services | 23.7 |
2 | Pharma | 12.88 |
3 | IT | 11.46 |
4 | Industrial Manufacturing | 10.93 |
5 | Construction | 6.67 |
6 | Services | 6.3 |
7 | Consumer Goods | 6 |
8 | Cement & Cement Products | 5.22 |
9 | Automobile | 4.58 |
10 | Telecom | 3.79 |
11 | Energy | 2.15 |
12 | Chemicals | 1.55 |
13 | Cash, Cash Equivalent and others | 4.77 |
S.No. | Holding Name | Net Assets (in %) |
1 | ICICI Bank Ltd. | 7.64 |
2 | ELGI Equipments Ltd. | 6.94 |
3 | State Bank of India | 6.17 |
4 | Cash, Cash Equivalent and others | 4.77 |
5 | Infosys Ltd. | 3.09 |
6 | Sadbhav Engineering Ltd. | 3.09 |
7 | Info Edge (India) Ltd. | 2.71 |
8 | Equitas Holdings Ltd. | 2.63 |
9 | Aurobindo Pharma Ltd. | 2.51 |
10 | Sun Pharmaceutical Industries Ltd. | 2.45 |
Launch Date- July 14 03, 1999
Fund Manager- Mr. Dinesh Balachandran
Risk- Moderately High
Benchmark- S&P BSE 500 Index
Return Since Launch- 18.40%
AUM- Rs. 1563.22 crore (as on 31st Mar, 2019)
Following is the performance of SBI Contra Fund-
| 1-Year | 3-Year | 5-Year | 10-Year |
Fund | -4.64 | 9.97 | 12.20 | 12.61 |
S&P BSE 500 TRI | 4.29 | 14.97 | 13.99 | 15.44 |
Category | -3.34 | 12.42 | 15.39 | 17.68 |
Rank within Category | 9 | 11 | 12 | 12 |
Number of funds in category | 14 | 14 | 13 | 12 |
As on Apr 25, 2019 |